XXIV World Congress
International Society for Heart Research

12–15 June 2022 • Berlin, Germany

Congress Details

Industrial symposia

Bayer AG
Leverkusen/ Germany

12 June, 17:15: "Stimulating Soluble Guanylate Cyclase in Patients Following a Worsening HF Event"

AstraZeneca GmbH
Wedel / Germany

13 June, 12:00: "Breaking the cycle of worsening metabolic, renal and cardiovascular disease step by step, our commitment to cardiometabolic medicines"

Novartis Pharma GmbH
Nürnberg / Germany

14 June, 12:45: "New frontiers in lipid management: the advent of RNA-based therapies"